(Q46821420)

25 December 2017

title

High serum galectin-3 in advanced melanoma: preliminary results (English)

1 reference

25 December 2017

author name string

Vereecken P

1

1 reference

25 December 2017

Zouaoui Boudjeltia K

2

1 reference

25 December 2017

Debray C

3

1 reference

25 December 2017

Awada A

4

1 reference

25 December 2017

Legssyer I

5

1 reference

25 December 2017

Sales F

6

1 reference

25 December 2017

Petein M

7

1 reference

25 December 2017

Vanhaeverbeek M

8

1 reference

25 December 2017

Ghanem G

9

1 reference

25 December 2017

Heenen M

10

1 reference

25 December 2017

publication date

1 January 2006

1 reference

25 December 2017

Clinical and Experimental Dermatology

published in

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

105-109

1 reference

25 December 2017

Galectins: a family of animal beta-galactoside-binding lectins.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Principles of structures of animal and plant lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Modulation of the biological functions of galectin-3 by matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Secretion of the galectin family of mammalian carbohydrate-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Galectins in cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Multifaceted role of galectin-3 on human glioblastoma cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Galectin-3 and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Elevated serum levels of S100 and survival in metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Serological markers for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

The role of galectins in the initiation, amplification and resolution of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Galectins as inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2005.01992.X

10.1111/J.1365-2230.2005.01992.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16309497

1 reference

25 December 2017